Deinum J, Derkx F H, Danser A H, Schalekamp M A
Department of Internal Medicine I, University Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands.
Endocrinology. 1990 Mar;126(3):1673-82. doi: 10.1210/endo-126-3-1673.
Angiotensin-II, the most important biologically active product of the renin-angiotensin system, has been reported to play a role in neovascularization, and prorenin has been found in the vitreous of human eyes, particularly in those affected by proliferative diabetic retinopathy, a disease characterized by neovascularization. The prorenin level in these eyes was, relative to that of plasma albumin, higher than in eyes without neovascularization. These findings suggested that an intraocular renin-angiotensin system exists, which might be involved in the development of retinal neovascularization in diabetes mellitus. In this study angiotensin-I-generating activity was measured in bovine aqueous humor and vitreous and in extracts of bovine retina, pigment epithelium-choroid, and anterior uveal tract before and after subjecting these extracts to procedures known to convert prorenin to renin. The measurements were made by incubation at 37 C with plasma from nephrectomized rats at pH ranging from 5.0-8.5. True renin in the ocular samples could be separated from nonrenin acid protease by alpha-casein-Sepharose affinity column chromatography at pH 3.5; true renin did not bind to the column, whereas acid protease did. True renin was further identified by its relatively high pH optimum (6.5-7.0) for angiotensin-I generation, its complete inhibition with specific renin antiserum, and its high affinity for specific renin inhibitors. More than 75% of angiotensin-I-generating activity of the ocular samples consisted of true renin. Approximately 90% or more of total renin (renin plus prorenin) in aqueous humor, vitreous, and ocular tissue could not be explained by trapped plasma. Total renin in aqueous humor and renin in vitreous were near the detection limit of the assay of angiotensin-I-generating activity. In vitreous prorenin comprised 99% of the total renin, in retina 81%, and in pigment epithelium-choroid and anterior uveal tract less than 50%. Prorenin in ocular fluids showed a concentration gradient, posterior vitreous greater than anterior vitreous greater than aqueous humor, suggesting that the main source of extracellular prorenin was in the posterior eye. These data support the contention of local renin and/or prorenin synthesis in the eye and are in accordance with the observations in other tissues that extrarenal synthesis of renin is often associated with the release of mainly, or exclusively, prorenin into extracellular fluid.
血管紧张素 II 是肾素 - 血管紧张素系统最重要的生物活性产物,据报道其在新生血管形成中发挥作用,并且在人眼玻璃体内发现了肾素原,尤其是在那些患有增殖性糖尿病视网膜病变的患者眼中,该疾病的特征是新生血管形成。相对于血浆白蛋白,这些眼睛中的肾素原水平高于无新生血管形成的眼睛。这些发现表明眼内存在肾素 - 血管紧张素系统,这可能参与糖尿病视网膜新生血管形成的发展。在本研究中,在将牛房水、玻璃体以及牛视网膜、色素上皮 - 脉络膜和眼前节提取物进行已知能将肾素原转化为肾素的处理之前和之后,测量了它们产生血管紧张素 I 的活性。测量是通过在 37℃下与肾切除大鼠的血浆在 pH 值为 5.0 - 8.5 的条件下孵育进行的。眼内样品中的真正肾素可以通过在 pH 3.5 下用α - 酪蛋白 - 琼脂糖亲和柱色谱法与非肾素酸性蛋白酶分离;真正的肾素不与柱子结合,而酸性蛋白酶则结合。通过其产生血管紧张素 I 的相对较高的最适 pH(6.5 - 7.0)、用特异性肾素抗血清完全抑制以及对特异性肾素抑制剂的高亲和力进一步鉴定真正的肾素。眼内样品中超过 75%的产生血管紧张素 I 的活性由真正的肾素组成。房水、玻璃体和眼组织中总肾素(肾素加肾素原)的约 90%或更多无法用滞留的血浆来解释。房水中总肾素和玻璃体内肾素接近产生血管紧张素 I 活性测定的检测限。玻璃体内肾素原占总肾素的 99%,视网膜中占 81%,色素上皮 - 脉络膜和眼前节中占不到 50%。眼内液中的肾素原呈现浓度梯度,玻璃体后部大于玻璃体前部大于房水,表明细胞外肾素原的主要来源在眼后部。这些数据支持眼内局部肾素和/或肾素原合成的观点,并且与其他组织中的观察结果一致,即肾外肾素合成通常与主要或仅将肾素原释放到细胞外液中相关。